-
Je něco špatně v tomto záznamu ?
CD44 and vimentin, markers involved with epithelial-mesenchymal transition: A proteomic analysis of sequential proteins extraction of triple-negative breast cancer cells after treatment with all-trans retinoic acid
D. Strouhalova, D. Macejova, M. Lastovickova, J. Brtko, J. Bobalova,
Jazyk angličtina Země Slovensko
Typ dokumentu časopisecké články
PubMed
32902409
DOI
10.4149/gpb_2020026
Knihovny.cz E-zdroje
- MeSH
- antigeny CD44 metabolismus MeSH
- epitelo-mezenchymální tranzice * MeSH
- lidé MeSH
- nádorové buněčné linie MeSH
- proteomika MeSH
- tretinoin farmakologie MeSH
- triple-negativní karcinom prsu metabolismus MeSH
- vimentin metabolismus MeSH
- Check Tag
- lidé MeSH
- Publikační typ
- časopisecké články MeSH
This work aimed to provide, in one isolation and separation step, an overview of the content of proteins with different solubility after treatment with all-trans retinoic acid, which is considered to be an important therapeutic agent, predominantly in acute promyelocytic leukemia. Breast, ovarian, bladder, and skin cancers have been demonstrated to be suppressed by retinoic acid, as well. The bottom-up proteomic strategies were applied for the analysis of proteins extracted from triple-negative breast cancer MDA-MB-231 cells utilizing a commercially manufactured kit. The gel electrophoresis followed by MALDI-TOF MS analysis was used for protein determination. By employing PDQuestTM software, we identified several proteins affected by all-trans retinoic acid. Two proteins, vimentin and CD44, which are associated with the epithelial-mesenchymal transition, were selected for a detailed study. We have found that all-trans retinoic acid results in significantly reduced levels of vimentin and CD44 in both the cytoplasmic and membrane fractions. A significant effect was particularly evident in CD44, where protein level in the cytoplasmic fraction was almost completely suppressed.
Citace poskytuje Crossref.org
- 000
- 00000naa a2200000 a 4500
- 001
- bmc20028051
- 003
- CZ-PrNML
- 005
- 20250819134957.0
- 007
- ta
- 008
- 210105s2020 xo f 000 0|eng||
- 009
- AR
- 024 7_
- $a 10.4149/gpb_2020026 $2 doi
- 035 __
- $a (PubMed)32902409
- 040 __
- $a ABA008 $b cze $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xo
- 100 1_
- $a Strouhalova, Dana $u Institute of Analytical Chemistry of the CAS, Brno, Czech Republic.
- 245 10
- $a CD44 and vimentin, markers involved with epithelial-mesenchymal transition: A proteomic analysis of sequential proteins extraction of triple-negative breast cancer cells after treatment with all-trans retinoic acid / $c D. Strouhalova, D. Macejova, M. Lastovickova, J. Brtko, J. Bobalova,
- 520 9_
- $a This work aimed to provide, in one isolation and separation step, an overview of the content of proteins with different solubility after treatment with all-trans retinoic acid, which is considered to be an important therapeutic agent, predominantly in acute promyelocytic leukemia. Breast, ovarian, bladder, and skin cancers have been demonstrated to be suppressed by retinoic acid, as well. The bottom-up proteomic strategies were applied for the analysis of proteins extracted from triple-negative breast cancer MDA-MB-231 cells utilizing a commercially manufactured kit. The gel electrophoresis followed by MALDI-TOF MS analysis was used for protein determination. By employing PDQuestTM software, we identified several proteins affected by all-trans retinoic acid. Two proteins, vimentin and CD44, which are associated with the epithelial-mesenchymal transition, were selected for a detailed study. We have found that all-trans retinoic acid results in significantly reduced levels of vimentin and CD44 in both the cytoplasmic and membrane fractions. A significant effect was particularly evident in CD44, where protein level in the cytoplasmic fraction was almost completely suppressed.
- 650 _2
- $a nádorové buněčné linie $7 D045744
- 650 12
- $a epitelo-mezenchymální tranzice $7 D058750
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a antigeny CD44 $x metabolismus $7 D018960
- 650 _2
- $a proteomika $7 D040901
- 650 _2
- $a tretinoin $x farmakologie $7 D014212
- 650 _2
- $a triple-negativní karcinom prsu $x metabolismus $7 D064726
- 650 _2
- $a vimentin $x metabolismus $7 D014746
- 655 _2
- $a časopisecké články $7 D016428
- 700 1_
- $a Macejova, Dana $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
- 700 1_
- $a Lastovickova, Marketa $u Institute of Analytical Chemistry of the CAS, Brno, Czech Republic.
- 700 1_
- $a Brtko, Julius $u Institute of Experimental Endocrinology, Biomedical Research Center, Slovak Academy of Sciences, Bratislava, Slovakia.
- 700 1_
- $a Bobáľová, Janette $u Institute of Analytical Chemistry of the CAS, Brno, Czech Republic. $7 xx0334836
- 773 0_
- $w MED00001896 $t General physiology and biophysics $x 0231-5882 $g Roč. 39, č. 4 (2020), s. 399-405
- 856 41
- $u https://pubmed.ncbi.nlm.nih.gov/32902409 $y Pubmed
- 910 __
- $a ABA008 $b sig $c sign $y a $z 0
- 990 __
- $a 20210105 $b ABA008
- 991 __
- $a 20250819134940 $b ABA008
- 999 __
- $a ok $b bmc $g 1608386 $s 1119231
- BAS __
- $a 3
- BAS __
- $a PreBMC
- BMC __
- $a 2020 $b 39 $c 4 $d 399-405 $e - $i 0231-5882 $m General physiology and biophysics $n Gen Physiol Biophys $x MED00001896
- LZP __
- $a Pubmed-20210105